Pub. Date : 2021
PMID : 34349829
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Therefore, we first detected the expression of PAD4 in EPCs of peripheral arterial disease and detected changes in the number and function of endothelial progenitor cells in peripheral blood after injecting the PAD4 inhibitor Cl-amidine into mice. | N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide | MMTV LTR integration site 4 | Mus musculus |
| 2 | Therefore, we first detected the expression of PAD4 in EPCs of peripheral arterial disease and detected changes in the number and function of endothelial progenitor cells in peripheral blood after injecting the PAD4 inhibitor Cl-amidine into mice. | N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide | MMTV LTR integration site 4 | Mus musculus |
| 3 | The results show that PAD4 is highly expressed in peripheral arterial diseases and the PAD4 inhibitor Cl-amidine can increase the number of EPCs and can treat peripheral arterial diseases by improving the proliferation, migration, and vascularization of EPCs. | N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide | MMTV LTR integration site 4 | Mus musculus |
| 4 | The results show that PAD4 is highly expressed in peripheral arterial diseases and the PAD4 inhibitor Cl-amidine can increase the number of EPCs and can treat peripheral arterial diseases by improving the proliferation, migration, and vascularization of EPCs. | N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide | MMTV LTR integration site 4 | Mus musculus |